The transcription factor Egr-1: a potential drug in wound healing and tissue repair

References

• Braddock M, Campbell C J, Zuder D. Current therapies for wound healing: electrical stimulation, biological therapeutics and the potential for gene therapy. Int J Dermatol 1999; 38: 808–17
   PubMed Web of Science ®Google Scholar
• Gashler A, Sukhatme V P. Early growth response protein 1 (Egr-1): prototype of a zinc-finger family of transcription factors. Prog Nucleic Acid Res Mol Biol 1995; 50: 191–224
   PubMed Web of Science ®Google Scholar
• Swirnoff A H, Milbrandt J. DNA-binding specificity of NGFI-A and related zinc finger transcription factors. Mol Cell Biol 1995; 15: 2275–87
   PubMed Web of Science ®Google Scholar
• Khachigian L M, Collins T. Inducible expression of Egr-1-dependent genes. A paradigm of transcriptional activation in vascular endothelium. Circ Res 1997; 81: 457–61
   PubMedGoogle Scholar
• Houston P, Dickson M C, Ludbrook V, White B P, Schwachtgen J -L, McVey J H, et al. Fluid shear stress activation of the tissue factor promoter in vitro and in vivo is mediated by Egr-1. Arterioscler Thromb Vasc Biol 1999; 19: 281–9
   PubMed Web of Science ®Google Scholar
• Lee S L, Sadovsky Y, Swirnoff A H, Polish J A, Goda P, Gavrilina G, et al. Luteinizing hormone deficiency and female infertility in mice lacking the transcription factor NGFI-A (Egr-1). Science 1996; 273: 1219–21
   PubMedGoogle Scholar
• Swiatek P J, Gridley T. Perinatal lethality and defects in hindbrain development in mice homozygous for a targeted mutation of the zinc finger gene Krox-20. Genes Dev 1993; 7: 2021–84
   Google Scholar
• Levi G, Topilko P, Schneider-Maunoury S, Lasagna M, Mantero S, Cancedda R, et al. Defective bane formation in Krox-20 mutant mice. Development 1996; 122: 113–20
   PubMedGoogle Scholar
• Levi G, Topilko P, Schneider-Maunoury S, Lasagna M, Mantero S, Pesce P, et al. Role of Krox-20 in endochondral bone formation. Ann N Y Acad Sci 1996; 785: 288–91
   PubMedGoogle Scholar
• Warner L E, Mancias P, Butler I J, McDonald C M, Keppen L, Koob K G, et al. Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies. Nat Genet 1998; 18: 382–4
   PubMed Web of Science ®Google Scholar
• Warner L E, Svaren J, Milbrandt J, Lupski J R. Functional consequences of mutations in the early growth response 2 gene (EGR2) correlate with severity of human myelinopathies. Hum Mol Genet 1999; 8: 1245–51
   PubMed Web of Science ®Google Scholar
• Brand E, Herrman S -M, Nicaud V, Evans A, Ruidavets J -B, Arveiler D, et al. Identification of two polymorphisms in the early growth response protein-1 gene: possible association with lipid variables. J Mol Med 2000; 78: 81–6
   PubMedGoogle Scholar
• Schwachtgen J -L, Campbell C J, Braddock M. Full promoter sequence of the human early growth response factor-1 (Egr-1): demonstration of a fifth functional serum response element. DNA Sequence 2000; 10: 429–32
   PubMedGoogle Scholar
• Yan S F, Zou Y S, Gao Y, Zhai C, Mackman N, Lee S L, et al. Tissue factor transcription driven by Egr-1 is a critical mechanism of murine pulmonary fibrin deposition in hypoxia. Proc Natl Acad Sci USA 1998; 95: 8298–303
   PubMed Web of Science ®Google Scholar
• Yan S -F, Lu J, Zou Y S, Soh-Won J, Cohen D M, Buttrick P M, et al. Hypoxia-associated induction of early growth response-1 gene expression. J Biol Chem 1999; 274: 15030–40
   PubMedGoogle Scholar
• Yan S -F, Fujita T, Lu J, Okada K, Zou Y S, Mackman N, et al. Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress. Nat Med 2000; 6: 1355–61
   PubMed Web of Science ®Google Scholar
• Yan S F, Lu J, Xu L, Zou Y S, Tongers J, Kisiel W, et al. Pulmonary expression of early growth response-1: biphasic time course and effect of oxygen concentration. J Appl Physiol 2000; 88: 2303–9
   PubMedGoogle Scholar
• Schwachtgen J -L, Houston P, Campbell C J, Sukhatme V, Braddock M. Fluid shear stress activation of Egr-1 transcription in cultured human endothelial and epithelial cells is mediated via the ERK1/2 MAP kinase pathway. J Clin Invest 1998; 101: 2540–9
   PubMed Web of Science ®Google Scholar
• Houston P, White B P, Campbell C J, Braddock M. Delivery and expression of fluid shear stress-inducible promoters to the vessel wall: applications for cardiovascular gene therapy. Hum Gene They 1999; 10: 3031–44
   PubMed Web of Science ®Google Scholar
• Akai Y, Homma T, Burns K D, Yasuda T, Badr K F, Harris R C. Mechanical stretch/relaxation of cultured rat mesangial cells induces protooncogenes and cyclooxygenase. Am J Physiol 1994; 267: C482–90
   PubMed Web of Science ®Google Scholar
• Dolce C, Kinniburgh A J, Dziak R. Immediate-early gene induction in rat osteoblastic cells after mechanical deformation. Arch Oral Biol 1996; 41: 1101–8
   PubMedGoogle Scholar
• Khachigian L M, Lindner V, Williams A J, Collins T. Egr-1 induced endothelial gene expression: a common theme in vascular injury. Science 1996; 271: 1427–31
   PubMedGoogle Scholar
• Liu L, Tsai J C, Aird W C. Egr-1 gene is induced by the systemic administration of vascular endothelial growth factor and epidermal growth factor. Blood 2000; 96: 1772–81
   PubMedGoogle Scholar
• Beckmann A M, Wilce P A. Egr transcription factors in the nervous system. Neurochem Int 1997; 31: 477–510
   PubMed Web of Science ®Google Scholar
• Halvorson L M, Kaiser U B, Chin W W. The protein kinase C system acts through the early growth response protein 1 to increase LHbeta gene expression in synergy with steroidogenic factor-1. Mol Endocrinol 1999; 13: 106–16
   PubMedGoogle Scholar
• Zhang Z, Yang X -Y, Cohen D M. Hypotonicity activates transcription through ERK-dependent and -independent pathways in renal cells. Am J Physiol 1998; 275: C1104–12
   PubMedGoogle Scholar
• Reddy G R, Zawia N H. Lead exposure alters Egr-1 binding in the neonatal rat brain. Int J Develop Neurosci 2000; 18: 791–5
   PubMed Web of Science ®Google Scholar
• Thiriet N, Aunis D, Zwiller J. C-fos and Egr-1 immediate-early gene induction by cocaine and cocaethylene in rat brain: a comparative study. Ann N Y Acad Sci 2000; 914: 46–57
   PubMedGoogle Scholar
• Depaz I M, Goodenough S, Wilce P A. Chronic ethanol has region-selective effects on Egr-1 and Egr-3 DNA-binding activity and protein expression in the rat brain. Neurochem Int 2000; 37: 473–82
   PubMedGoogle Scholar
• Marples B, Hendry J H, Lashford L S, Embleton M J, Hunter R D, Howell A, et al. A radiation-controlled molecular switch for use in gene therapy of cancer. Gene Ther 2000; 7: 1121–5, 2000
   PubMedGoogle Scholar
• Braddock M, Schwachtgen J -L, Campbell C J. Glaxo Group Ltd. WO-09962561, 1999, patent
   Google Scholar
• Braddock M, Campbell C J, Houston P. Therapeutic applications of the transcriptional co-repressor proteins NAB1 and NAB2 in regenerative medicine. IDrugs 2000; 3: 783–7
   PubMedGoogle Scholar
• Russo M W, Sevetson B R, Milbrandt J. Indentification of NAB1, a repressor of NGF1-A- and Krox-20-mediated transcription. Proc Natl Acad Sci USA 1995; 92: 6873–7
   PubMed Web of Science ®Google Scholar
• Svaren J, Sevetson B R, Apel E D, Zimonjic D B, Popescu N C, Milbrandt J. NAB2, a corepressor of NGFI-A (Egr-1) and Krox20, is induced by proliferative and differentiative stimuli. Mol Cell Biol 1996; 16: 3545–33
   PubMed Web of Science ®Google Scholar
• Qu Z., Wolfraim L A, Svaren J, Ehrengruber M U, Davidson N, Milbrandt J. The transcriptional corepressor NAB2 inhibits NGF-induced differentiation of PC12 cells. J Cell Biol 1998; 142: 1075–82
   PubMedGoogle Scholar
• Silverman E S, Khachigian L M, Santiago F S, Williams A J, Lindner V, Collins T. Vascular smooth muscle cells express the transcriptional corepressor NAB2 in response to injury. Am J Pathol 1999; 155: 1311–7
   PubMedGoogle Scholar
• Svaren J, Sevetson B R, Golda T, Stanton J J, Swirnoff A H, Milbrandt J. Novel mutants of NAB corepressors enhance activation by Egr transactivators. EMBO J 1998; 17: 6010–9
   PubMedGoogle Scholar
• Houston P, Campbell C J, Svaren J, Milbrandt J, Braddock M. The transcriptional corepressor NAB2 blocks Egr-1 mediated growth factor activation and angiogenesis. Biochem Biophys Res Commun 2001; 238: 480–6
   Google Scholar
• Miano J M, Berk B C. NAB2: A transcriptional brake for activated gene expression in the vessel wall. Am J Pathol 1999; 155: 1009–12
   PubMedGoogle Scholar
• Bryant M, Drew G M, Houston P, Hissey P, Campbell C J, Braddock M. Tissue repair with a therapeutic transcription factor. Hum Gene Ther 2000; 11: 2143–58
   PubMed Web of Science ®Google Scholar
• McMahon A P, Champion J E, McMahon J A, Sukhatme V P. Developmental expression of the putative transcription factor Egr-1 suggests that Egr-1 and c-fos are coregulated in some tissues. Development 1990; 108: 281–7
   PubMed Web of Science ®Google Scholar
• Sugiura T. Cloning and functional characterisation of the 5′-flanking region of the human bone morphogenetic protein-2 gene. Biochem J 1999; 338: 433–40
   PubMedGoogle Scholar
• Shore E M, Xu M -Q, Shah P B, Janoff H B, Hahn G V, Deardoff M A, et al. The human bone morphogenetic protein 4 (BMP-4) gene: molecular structure and transcriptional regulation. Calcif Tissue Int 1998; 63: 221–9
   PubMedGoogle Scholar
• Gitelman S E, Kobrin M, Lee A, Fet V, Lyons K, Hogan B LM, et al. Structure and sequence of the mouse Bmp6 gene. Mammalian Genome 1997; 8: 212–4
   PubMedGoogle Scholar
• Khachigian L M, Collins T. Inducible expression of Egr-1 dependent genes. A paradigm of transcriptional activation in vascular endothelium. Circ Res 1997; 81: 456–61
   Google Scholar
• Wada Y, Suzuki J, Tsukioka K, Zhang T, Takayama K, Endoh M, et al. Expression of the transcription factor Egr-1/BTEB2 in cardiac xenograft remodelling. Transplant Proc 2000; 32: 1089–91
   PubMedGoogle Scholar
• Herdegen T. Egr transcription factors in the nervous system. Neurochem Int 1997; 31: 511–6
   Google Scholar
• McCaffrey T, Fu C, Du B, Eksinar S, Kent K C, Bush H, Jr, et al. High-level expression of Egr-1 and Egr-1-inducible genes in mouse and human atherosclerosis. J Clin Invest 2000; 105: 653–62
   PubMed Web of Science ®Google Scholar
• Zhang W, Yan S D, Zhu A, Zou Y S, Williams M, Godman G C, et al. Expression of Egr-1 in late stage emphysema. Am J Pathol 2000; 157: 1311–20
   PubMedGoogle Scholar
• Grimbacher B, Aicher W K, Peter H H, Eibel H. TNF-alpha induces the transcription factor Egr-1, pro-inflammatory cytokines and cell proliferation in human skin fibroblasts and synovial lining cells. Rheumatol Int 1998; 17: 185–92
   PubMedGoogle Scholar
• Aicher W K, Dinkel A, Grimbacher B, Haas C v, Seydlitz-Kurzbach E, Peter H H, et al. Serum response elements activate a CAMP responsive elements inhibit expression of transcription factor Egr-1 in synovial fibroblasts of rheumatoid arthritis patients. Int Immunol 1998; 11: 47–61
   Google Scholar
• Parak W J, Dannohl S, George M, Schuler M K, Schaumburger J, Gaub H E, et al. Metabolic activation stimulates acid production in synovial fibroblasts. J Rheumatol 2000; 27: 2312–22
   PubMedGoogle Scholar
• Wang F -L, Connor J R, Dodds R A, James I E, Kumar S, Zou C, et al. Differential expression of Egr-1 in osteoarthritic compared to normal adult human cartilage. Osteoarthritis Cartilage 2000; 8: 161–9
   PubMedGoogle Scholar
• Hatori M, Klatte K J, Teixeira C C, Shapiro I M. End labelling studies of fragmented DNA in the avian growth plate: evidence of apoptosis in terminally differentiated chondrocytes. J Bone Min Res 1995; 10: 1960–8
   PubMedGoogle Scholar
• Zenmyo M, Komiya S, Kawabata R, Sasaguri Y, Inoue A, Morimatsu M. Morphological and biochemical evidence for apoptosis in the terminal hypertrophic chondrocytes of the growth plate. J Pathol 1996; 180: 430–3
   PubMed Web of Science ®Google Scholar
• Blanco F J, Guitan R, Vasquez-Mad E, Toror F J, Galdo F. Osteoarthritis chondrocytes die by apoptosis. A possible pathway for osteoarthritis pathology. Arthritis Rheum 1998; 41: 284–9
   PubMed Web of Science ®Google Scholar
• Kouri J B, Rosales-Encina J L, Chaudhuri P P, Luna J, Mena R. Apoptosis in medial osteoarthritic cartilage: a microscopy report. Med Sci Res 1997; 25: 245–8
   Google Scholar
• Liu C, Rangnekar V M, Adamson E, Mercola D. Suppression of growth and transformation and induction of apoptosis by Egr-1. Cancer Gene Ther 1998; 5: 3–28
   PubMed Web of Science ®Google Scholar